“We are humbled to be featured in the Gates Notes. At TASK we feel that TB is a global challenge and something we all should fight collectively. I hope that by having our story shared, this will inspire others to partner with us in some way to eradicate this disease” Andreas Diacon Good news in…
TASK Applied Science (TASK) is a clinical research centre in Cape Town, South Africa with a focus on performing clinical trials in tuberculosis (TB). TASK provides assistance to efficiently conduct studies for diagnosis, treatment or prevention of tuberculosis, as well as for other prevalent diseases such as asthma, osteoarthritis and vaccine studies like respiratory syncytial virus (RSV), where new and improved treatments are urgently needed.
The company was founded in 2005 by Prof. Andreas Diacon to accelerate the development and evaluation of novel anti-tuberculosis drugs. TASK mainly collaborates with international NGOs, government funded consortia, academic centers and pharmaceutical companies on various drug development projects.
TASK now employs over 180 staff members, has invested in state of the art bio-safety level 3 laboratory capacity as well as a network of clinical sites in Cape Town.